NASDAQ: CUECue Biopharma Inc Stock Ownership - Who owns Cue Biopharma?
Insider buying vs selling
Have Cue Biopharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Sumita Ray | CLO | 2026-08-13 | 6,442 | $30.35 | $195.51kSell |
| Sumita Ray | CLO | 2026-08-13 | 4 | $31.13 | $124.52Sell |
| Shaolee Lin | CEO | 2026-08-13 | 5,423 | $27.19 | $147.45kSell |
| Shaolee Lin | CEO | 2026-08-13 | 2,375 | $28.11 | $66.76kSell |
| Shaolee Lin | CEO | 2026-08-13 | 10,460 | $29.48 | $308.36kSell |
| Michael Vincent Meluzio | VP | 2026-08-13 | 1,519 | $29.37 | $44.61kSell |
| Michael Vincent Meluzio | VP | 2026-08-13 | 4,106 | $30.35 | $124.62kSell |
| Michael Vincent Meluzio | VP | 2026-08-13 | 3 | $31.13 | $93.39Sell |
| Sumita Ray | CLO | 2026-08-13 | 2,383 | $29.37 | $69.99kSell |
| Shaolee Lin | CEO | 2026-08-12 | 34,225 | $26.99 | $923.73kSell |
CUE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CUE insiders and whales buy or sell their stock.
CUE Shareholders
What type of owners hold Cue Biopharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Cameron Gray | 17.66% | 1,283,249 | $32.81M | Insider |
| Aaron Gl Fletcher | 15.33% | 1,113,867 | $28.48M | Insider |
| Michael J. Fox | 15.14% | 1,100,000 | $28.13M | Insider |
| Christopher A. Marlett | 10.58% | 768,503 | $19.65M | Insider |
| Shaolee Lin | 9.72% | 705,995 | $18.05M | Insider |
| Ronald D. Seidel Iii | 6.13% | 445,000 | $11.38M | Insider |
| Rodolfo Chaparro | 6.13% | 445,000 | $11.38M | Insider |
| Daniel R. Passeri | 2.27% | 164,578 | $4.21M | Insider |
| Anish Suri | 1.87% | 135,638 | $3.47M | Insider |
| Sumita Ray | 1.63% | 118,545 | $3.03M | Insider |
CUE vs Biotech Stocks
Cue Biopharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.